This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Julian Adams, Ph.D., Of Infinity Pharmaceuticals Named Corporate Chair For The Leukemia & Lymphoma Society’s Light The Night Walk

The Massachusetts chapter of The Leukemia & Lymphoma Society (LLS) named Julian Adams, Ph.D., of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) as corporate chair of its 2014 Light The Night ® Walk, LLS’s annual fundraising event for cancer research and patient services. Dr. Adams serves as president, research and development, at Infinity and is responsible for the full spectrum of the company’s drug discovery, preclinical and clinical development strategy and regulatory affairs activities.

LLS holds walks each fall in approximately 200 communities across the United States and Canada. Participants at the walks carry illuminated balloons – white for survivors, red for supporters, and gold to remember those who have died – to honor and commemorate lives touched by blood cancer.

“Forming Light The Night Walk teams is a great way to build team spirit among employees, raise awareness about the need for more blood cancer therapies and recognize those who continue to be affected by these diseases,” said Dr. Adams. “These same objectives – and our desire to continue our support of LLS – led us to recently launch Infinity Pharmaceuticals’ “ Sparks of Inspiration” campaign. I am honored to serve as the chair of the 2014 Light The Night Walk and look forward to helping more local businesses and corporations get their employees involved.”

Prior to joining Infinity in 2003, Dr. Adams served as senior vice president, drug discovery and development at Millennium Pharmaceuticals. In this capacity, he held global responsibility for multiple drug discovery programs, including the successful discovery and development of Velcade ® (bortezomib), a proteasome inhibitor for two different blood cancers: multiple myeloma and relapsed mantle cell lymphoma. He previously held senior management positions with organizations such as LeukoSite, ProScript, Inc. and Boehringer Ingelheim, where he successfully discovered the drug Viramune ® (nevirapine) for HIV. Dr. Adams’ awards include the 2012 Warren Alpert Foundation Prize for his role in the discovery and development of bortezomib, the 2012 C. Chester Stock Award Lectureship from Memorial Sloan-Kettering Cancer Center, and the 2001 Ribbon of Hope Award for Velcade ® from the International Myeloma Foundation.

The funds raised through corporate and individual contributions during the Light The Night ® Walk help to find cures and better therapies for leukemia, lymphoma, Hodgkin disease and myeloma. Donations also provide information, education and support for patients and their families.

“Light The Night Walk gives hope to patients and their families and lets them know they are not alone in their battle against cancer,” said Sharon Klein, executive director of the Massachusetts chapter of the LLS.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,476.22 -87.08 -0.53%
S&P 500 1,919.83 -10.84 -0.56%
NASDAQ 4,332.77 -37.0030 -0.85%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs